A sars-cov-2 human parainfluenza virus type 3-vectored vaccine

Alexander Bukreyev (Inventor), Philipp Ilinykh (Inventor), Sivakumar Periasamy (Inventor), Kai Huang (Inventor)

Research output: Patent

Abstract

Certain embodiments are directed to a new human parainfluenza virus (HPIV)/SARS-CoV-2 vaccine or vaccine construct/polynucleotide. In certain aspects the vaccine or vaccine construct is administered via intranasal administration.
Original languageEnglish (US)
Patent numberWO2023133227A2
Filing date1/5/23
StatePublished - Jul 13 2023

Fingerprint

Dive into the research topics of 'A sars-cov-2 human parainfluenza virus type 3-vectored vaccine'. Together they form a unique fingerprint.

Cite this